T. Rowe Price Associates
HELE icon

T. Rowe Price Associates’s Helen of Troy HELE Stock Holding History

T. Rowe Price Associates’s Portfolio HELE Stock Details HELE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$574K Buy
39,739
+5,781
+17% +$101K ﹤0.01% 2388
2025
Q4 		$722K Buy
33,958
+9,267
+38% +$189K ﹤0.01% 2229
2025
Q3 		$623K Buy
24,691
+695
+3% +$16.8K ﹤0.01% 2286
2025
Q2 		$682K Buy
23,996
+1,296
+6% +$39.8K ﹤0.01% 2155
2025
Q1 		$1.22M Buy
22,700
+949
+4% +$54.8K ﹤0.01% 1857
2024
Q4 		$1.3M Buy
21,751
+1,621
+8% +$108K ﹤0.01% 1858
2024
Q3 		$1.25M Buy
20,130
+1,072
+6% +$63.4K ﹤0.01% 1878
2024
Q2 		$1.77M Buy
19,058
+766
+4% +$77.6K ﹤0.01% 1615
2024
Q1 		$2.11M Buy
18,292
+848
+5% +$101K ﹤0.01% 1538
2023
Q4 		$2.11M Buy
17,444
+866
+5% +$93.3K ﹤0.01% 1509
2023
Q3 		$1.93M Buy
16,578
+112
+0.7% +$13.9K ﹤0.01% 1477
2023
Q2 		$1.78M Sell
16,466
-35,120
-68% -$3.36M ﹤0.01% 1529
2023
Q1 		$4.91M Buy
51,586
+6,691
+15% +$716K ﹤0.01% 1187
2022
Q4 		$4.98M Sell
44,895
-55,439
-55% -$5.4M ﹤0.01% 1190
2022
Q3 		$9.68M Sell
100,334
-4,750
-5% -$610K ﹤0.01% 1072
2022
Q2 		$17.1M Sell
105,084
-19,938
-16% -$3.76M ﹤0.01% 1214
2022
Q1 		$24.5M Sell
125,022
-39,808
-24% -$8.39M ﹤0.01% 1179
2021
Q4 		$40.3M Sell
164,830
-96,018
-37% -$22.8M ﹤0.01% 1077
2021
Q3 		$58.6M Sell
260,848
-31,198
-11% -$7.14M 0.01% 956
2021
Q2 		$66.6M Sell
292,046
-173,088
-37% -$38.1M 0.01% 930
2021
Q1 		$98M Sell
465,134
-37,373
-7% -$8.43M 0.01% 785
2020
Q4 		$112M Sell
502,507
-6,611
-1% -$1.36M 0.01% 693
2020
Q3 		$98.5M Sell
509,118
-1,722
-0.3% -$342K 0.01% 658
2020
Q2 		$96.3M Sell
510,840
-4,671
-0.9% -$764K 0.01% 649
2020
Q1 		$74.2M Buy
515,511
+4,051
+0.8% +$686K 0.01% 660
2019
Q4 		$92M Buy
511,460
+11,494
+2% +$1.84M 0.01% 692
2019
Q3 		$78.8M Buy
499,966
+580
+0.1% +$86.2K 0.01% 702
2019
Q2 		$65.2M Sell
499,386
-3,120
-0.6% -$408K 0.01% 789
2019
Q1 		$58.3M Buy
502,506
+43,766
+10% +$5.05M 0.01% 814
2018
Q4 		$60.2M Buy
458,740
+807
+0.2% +$106K 0.01% 754
2018
Q3 		$59.9M Buy
457,933
+8,234
+2% +$970K 0.01% 844
2018
Q2 		$44.3M Buy
449,699
+22,347
+5% +$2.04M 0.01% 943
2018
Q1 		$37.2M Buy
427,352
+8,340
+2% +$759K 0.01% 971
2017
Q4 		$40.4M Sell
419,012
-11,339
-3% -$1.04M 0.01% 943
2017
Q3 		$41.7M Buy
430,351
+21,776
+5% +$2.09M 0.01% 923
2017
Q2 		$38.4M Buy
408,575
+11,397
+3% +$1.06M 0.01% 930
2017
Q1 		$37.4M Buy
397,178
+17,872
+5% +$1.69M 0.01% 914
2016
Q4 		$32M Buy
379,306
+3,140
+0.8% +$263K 0.01% 970
2016
Q3 		$32.4M Buy
376,166
+34,150
+10% +$3.2M 0.01% 955
2016
Q2 		$35.2M Buy
342,016
+8,006
+2% +$808K 0.01% 903
2016
Q1 		$34.6M Sell
334,010
-4,560
-1% -$426K 0.01% 907
2015
Q4 		$31.9M Buy
338,570
+32,070
+10% +$3.21M 0.01% 930
2015
Q3 		$27.4M Buy
306,500
+26,500
+9% +$2.37M 0.01% 979
2015
Q2 		$27.3M Buy
280,000
+18,000
+7% +$1.58M 0.01% 1051
2015
Q1 		$21.4M Buy
262,000
+15,100
+6% +$1.15M ﹤0.01% 1108
2014
Q4 		$16.1M Sell
246,900
-500
-0.2% -$30.8K ﹤0.01% 1183
2014
Q3 		$13M Buy
247,400
+4,500
+2% +$252K ﹤0.01% 1236
2014
Q2 		$14.7M Buy
242,900
+27,000
+13% +$1.68M ﹤0.01% 1212
2014
Q1 		$14.9M Buy
215,900
+16,500
+8% +$1M ﹤0.01% 1190
2013
Q4 		$9.87M Buy
199,400
+44,400
+29% +$2.08M ﹤0.01% 1288
2013
Q3 		$6.85M Buy
155,000
+144,500
+1,376% +$6.08M ﹤0.01% 1366
2013
Q2 		$403K Buy
+10,500
New +$399K ﹤0.01% 1951

Other funds holding HELE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RWWM Inc Rocklin, California $1.37B AUM 3.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

T. Rowe Price Associates's HELE Position: Q1 2026 in Review

T. Rowe Price Associates increased its Helen of Troy (HELE) stake by 17% in Q1 2026, buying an estimated $101K and bringing the position to 39,739 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

T. Rowe Price Associates first reported a position in HELE in Q2 2013 and has held it in 52 quarters since. The position peaked at $112M in Q4 2020. 187 funds tracked by Wall St. Rank hold HELE as of Q1 2026.

  • T. Rowe Price Associates held 39,739 shares of Helen of Troy worth $574K as of Q1 2026.
  • T. Rowe Price Associates bought 5,781 Helen of Troy shares in Q1 2026, an estimated $101K.
  • Helen of Troy made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2388 holding.
  • T. Rowe Price Associates first reported a position in Helen of Troy in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Helen of Troy position peaked at $112M in Q4 2020.
  • 187 funds tracked by Wall St. Rank held Helen of Troy as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.